Josep M. Llovet is Founder and Director of the Liver Cancer Program and Full Professor of Medicine at the Mount Sinai School of Medicine, New York University (USA), and Professor of Research-ICREA in the BCLC Group, Liver Unit, IDIBAPS-Hospital Clínic, University of Barcelona. Professor Llovet obtained his degree in Medicine and Surgery from the University of Barcelona in 1986 and his Ph.D. from the Autonomous University of Barcelona in 1995.
Professor Llovet has been President, Secretary and Founder of the International Liver Cancer Association (ILCA) and Chairman of the European Clinical Practice Guidelines of management of liver cancer (EASL-EORTC). He has published more than 240 articles in peer-reviewed journals such as New England Journal of Medicine, Nature, Nature Genetics, Lancet, Lancet Oncology, Cancer Cell, Nature Rev Dis Primers, Nature Biotech, Nature Com, Nature Rev Clin Oncol, JCO, J Clin Invest, JNCI and Gastroenterology (total citations 43.560, total impact factor 2660; h index 85), more than 50 chapters of books, and has delivered more than 500 lectures. He is Senior Editor of Clinical Cancer Research. Of note, he has been recognized as a) Top-1% cited researcher in Thomson Reuters, 2014-2016, and b) #1 Most cited investigator in Spain, period 1997-2011.